4/A

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: May 22, 2013
Period of Report: May 6, 2013
Accession Number: 0001237899-13-000037

View Document ↗ View on SEC.gov ↗